The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. 2017

Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
Department of Genetics, Ribeirão Preto Medical School, University of São Paulo (USP), Avenida Bandeirantes 3900, 14048-900, Ribeirão Preto, SP, Brazil. augustofaria@usp.br.

Medulloblastoma (MB) is the most common solid tumor among pediatric patients and corresponds to 20 % of all pediatric intracranial tumors in this age group. Its treatment currently involves significant side effects. Epigenetic changes such as DNA methylation may contribute to its development and progression. DNA methyltransferase (DNMT) inhibitors have shown promising anticancer effects. The agent Zebularine acts as an inhibitor of DNA methylation and shows low toxicity and high efficacy, being a promising adjuvant agent for anti-cancer chemotherapy. Several studies have reported its effects on different types of tumors; however, there are no studies reporting its effects on MB. We analyzed its potential anticancer effects in four pediatric MB cell lines. The treatment inhibited proliferation and clonogenicity, increased the apoptosis rate and the number of cells in the S phase (p < 0.05), as well as the expression of p53, p21, and Bax, and decreased cyclin A, Survivin and Bcl-2 proteins. In addition, the combination of zebularine with the chemotherapeutic agents vincristine and cisplatin resulted in synergism and antagonism, respectively. Zebularine also modulated the activation of the SHH pathway, reducing SMO and GLI1 levels and one of its targets, PTCH1, without changing SUFU levels. A microarray analysis revealed different pathways modulated by the drug, including the Toll-Like Receptor pathway and high levels of the BATF2 gene. The low expression of this gene was associated with a worse prognosis in MB. Taken together, these data suggest that Zebularine may be a potential drug for further in vivo studies of MB treatment.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008527 Medulloblastoma A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1) Arachnoidal Cerebellar Sarcoma, Circumscribed,Medulloblastoma, Desmoplastic,Medullomyoblastoma,Sarcoma, Cerebellar, Circumscribed Arachnoidal,Medulloblastoma, Adult,Medulloblastoma, Childhood,Melanocytic Medulloblastoma,Adult Medulloblastoma,Adult Medulloblastomas,Childhood Medulloblastoma,Childhood Medulloblastomas,Desmoplastic Medulloblastoma,Desmoplastic Medulloblastomas,Medulloblastoma, Melanocytic,Medulloblastomas,Medulloblastomas, Adult,Medulloblastomas, Childhood,Medulloblastomas, Desmoplastic,Medulloblastomas, Melanocytic,Medullomyoblastomas,Melanocytic Medulloblastomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002528 Cerebellar Neoplasms Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141) Benign Cerebellar Neoplasms,Cerebellar Cancer,Malignant Cerebellar Neoplasms,Cerebellar Neoplasms, Benign,Cerebellar Neoplasms, Malignant,Cerebellar Neoplasms, Primary,Cerebellar Tumors,Neoplasms, Cerebellar,Neoplasms, Cerebellar, Benign,Neoplasms, Cerebellar, Malignant,Neoplasms, Cerebellar, Primary,Primary Neoplasms, Cerebellum,Benign Cerebellar Neoplasm,Cancer, Cerebellar,Cerebellar Cancers,Cerebellar Neoplasm,Cerebellar Neoplasm, Benign,Cerebellar Neoplasm, Malignant,Cerebellar Neoplasm, Primary,Cerebellar Tumor,Cerebellum Primary Neoplasm,Cerebellum Primary Neoplasms,Malignant Cerebellar Neoplasm,Neoplasm, Benign Cerebellar,Neoplasm, Cerebellar,Neoplasm, Cerebellum Primary,Neoplasm, Malignant Cerebellar,Primary Cerebellar Neoplasm,Primary Cerebellar Neoplasms,Primary Neoplasm, Cerebellum,Tumor, Cerebellar
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine

Related Publications

Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
January 2012, Molecular vision,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
April 2010, Breast cancer research and treatment,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
May 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
January 2012, PloS one,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
January 2013, PloS one,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
January 1993, Acta oncologica (Stockholm, Sweden),
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
May 2011, Journal of neuro-oncology,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
January 2015, PloS one,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
August 2019, Molecular reproduction and development,
Augusto Faria Andrade, and Kleiton Silva Borges, and Veridiana Kiill Suazo, and Lenisa Geron, and Carolina Alves Pereira Corrêa, and Angel Mauricio Castro-Gamero, and Elton José Rosas de Vasconcelos, and Ricardo Santos de Oliveira, and Luciano Neder, and José Andres Yunes, and Simone Dos Santos Aguiar, and Carlos Alberto Scrideli, and Luiz Gonzaga Tone
November 2022, International journal of molecular sciences,
Copied contents to your clipboard!